University & Research Institutions

New patent politics put US public-private partnerships under threat, says BIO’s IP chief

In an exclusive interview, Hans Sauer talks of concerns over a shift in federal strategy and argues that government research funding should not be seen as a commercial investment

New patent politics put US public-private partnerships under threat, says BIO’s IP chief
PARC goes on patent offensive against Facebook, Snap and Twitter
30 Nov 2020

PARC goes on patent offensive against Facebook, Snap and Twitter

Very rare assertion campaign by the Xerox subsidiary sees three suits filed in US district court against social media giants

US legislators move to close another “evergreening loophole” for orphan drugs
24 Nov 2020

US legislators move to close another “evergreening loophole” for orphan drugs

Recent reforms have made it harder to obtain regulatory exclusivity for follow-on versions of rare disease treatments

Latest

View all
19 Nov 2020

Your guide to covid-19 vaccine stakeholders’ IP strategies

IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations Read more

18 Nov 2020

Samsung taps outside patent lab while spending record amounts on its own R&D

Company is not the only South Korean giant to tap the secondary market as it does more in-house research than ever Read more

17 Nov 2020

Data is the new frontier in healthcare IP licensing, says award-winning TTO

IAM speaks to the tech transfer office of Oregon Health & Science University about the keys to success in university-industry deal-making Read more

10 Nov 2020

There has never been a better time to sell or buy drug royalties, says industry veteran

IAM speaks to leading deal-maker David MacNaughtan about his new fund and the growth of this form of life sciences IP monetisation Read more

News

View all
24 Oct 2020

To educate lawyers who change the world, we cannot let this crisis go to waste

As the covid-19 pandemic continues to upend education in the US and beyond, there is an opportunity to create a new normal in how IP is taught, says Megan Carpenter, Dean of the Franklin Pierce School of Law Read more

15 Sep 2020

Confronting critical challenges, Taiwan’s tech companies must find a way to create patent value

IAM speaks with IP leaders from Foxconn, AU Optronics and others ahead of IPBC Taiwan next week Read more

14 Sep 2020

Changes to Ukraine’s IP laws have major implications for the life sciences

Two recent pieces of legislation have brought the country’s patent system more closely in line with EU rules Read more

12 Sep 2020

It’s the PTAB, stupid

Whether the US chooses four more years of Donald Trump or Joe Biden replaces him, big tech's assault on the PTO shows where the patent policy battle lines are being drawn Read more

Analysis

View all
9 Nov 2020

Applicants beware: patent oppositions are off the charts in India

Nearly 300% increase over a three-year span indicates greater attention being paid to publications in a jurisdiction where disputes are rising Read more

6 Nov 2020

Meet the IV veteran creating an IP licensing business in the pharma space

Connie Wan of Seattle Gummy Company talks to IAM about the lessons she learned at the mega-NPE Read more

5 Nov 2020

Intel’s legal manoeuvrings illustrate varied NPE threat in China

American chipmaker has faced down a big global licensor, a homegrown NPE and a powerful state-linked research organisation Read more

4 Nov 2020

Amgen suffers another setback in antibody IP war

EPO invalidates PCSK9 patent ahead of crucial CAFC case to be heard next month Read more

Insights

View all
12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

12 Aug 2020

As the fallout from covid continues, the two IP superpowers offer different messages

While China cheers an uptick in applications, the USPTO warns of a prolonged downturn Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

24 May 2019

IP market news highlights

Some of the major news stories carried on the IAM platform from March to mid-May. Read more